ArticleCancers2025

Contemporary Clinical Utilization of Radioembolization with Immune Checkpoint Inhibitors as First-Line Treatment in HCC: Real-World Report on Safety and Outcomes.

Kelley G Núñez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.